Latest Insider Transactions at Amgen Inc (AMGN)
This section provides a real-time view of insider transactions for Amgen Inc (AMGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2020
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,796
-10.58%
|
$1,147,608
$198.76 P/Share
|
|
Mar 20
2020
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
3,709
-11.01%
|
$734,382
$198.76 P/Share
|
|
Mar 20
2020
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,591
-3.66%
|
$315,018
$198.76 P/Share
|
|
Mar 20
2020
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,481
-5.72%
|
$293,238
$198.76 P/Share
|
|
Mar 20
2020
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,855
-4.5%
|
$367,290
$198.76 P/Share
|
|
Mar 20
2020
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
6,465
-12.72%
|
$1,280,070
$198.76 P/Share
|
|
Mar 09
2020
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
780
-1.87%
|
$163,800
$210.65 P/Share
|
|
Mar 09
2020
|
David M Reese EVP & Chief Technology Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
1,480
-3.42%
|
$85,840
$58.43 P/Share
|
|
Mar 03
2020
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
55,683
+9.6%
|
-
|
|
Mar 03
2020
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
11,600
+17.53%
|
-
|
|
Mar 03
2020
|
Lori A Johnston EVP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
7,423
+18.13%
|
-
|
|
Mar 03
2020
|
Cynthia M Patton SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
3,711
+12.55%
|
-
|
|
Mar 03
2020
|
David Piacquad SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,711
+7.88%
|
-
|
|
Mar 03
2020
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,711
+8.43%
|
-
|
|
Mar 03
2020
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12,991
+20.42%
|
-
|
|
Feb 07
2020
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.74%
|
$106,722
$231.45 P/Share
|
|
Feb 06
2020
|
R Sanders Williams Director |
SELL
Open market or private sale
|
Direct |
425
-7.85%
|
$99,025
$233.72 P/Share
|
|
Feb 06
2020
|
David Piacquad SVP, Business Development |
SELL
Open market or private sale
|
Direct |
9,264
-18.92%
|
$2,121,456
$229.93 P/Share
|
|
Feb 04
2020
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.42%
|
-
|
|
Dec 13
2019
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,425
-4.72%
|
$569,875
$235.99 P/Share
|
|
Dec 13
2019
|
David Piacquad SVP, Business Development |
SELL
Exercise of conversion of derivative security
|
Direct |
2,875
-5.3%
|
$465,750
$162.6 P/Share
|
|
Nov 25
2019
|
David W Meline EVP & CFO |
SELL
Open market or private sale
|
Direct |
8,737
-15.03%
|
$2,044,458
$234.36 P/Share
|
|
Nov 22
2019
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Open market or private sale
|
Direct |
9,000
-17.36%
|
$2,070,000
$230.54 P/Share
|
|
Nov 20
2019
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,870
-9.13%
|
$1,090,880
$224.5 P/Share
|
|
Nov 20
2019
|
David Piacquad SVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,749
+9.73%
|
$896,844
$156.35 P/Share
|
|
Nov 06
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.17%
|
$430,000
$215.45 P/Share
|
|
Nov 06
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.85%
|
$108,000
$54.71 P/Share
|
|
Nov 06
2019
|
R Sanders Williams Director |
SELL
Open market or private sale
|
Direct |
425
-7.28%
|
$91,375
$215.45 P/Share
|
|
Nov 02
2019
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
5,812
-14.59%
|
$1,261,204
$217.95 P/Share
|
|
Nov 01
2019
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+4.74%
|
-
|
|
Nov 01
2019
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
261
+4.66%
|
-
|
|
Nov 01
2019
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
9,176
+15.04%
|
-
|
|
Nov 01
2019
|
Lori A Johnston EVP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
7,799
+22.77%
|
-
|
|
Oct 02
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.17%
|
$386,000
$193.58 P/Share
|
|
Oct 02
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.85%
|
$108,000
$54.71 P/Share
|
|
Sep 04
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.24%
|
$412,000
$206.7 P/Share
|
|
Sep 04
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.91%
|
$108,000
$54.71 P/Share
|
|
Aug 30
2019
|
Cynthia M Patton SVP & CCO |
SELL
Open market or private sale
|
Direct |
13,426
-15.04%
|
$2,792,608
$208.07 P/Share
|
|
Aug 30
2019
|
Cynthia M Patton SVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,624
+11.89%
|
$1,371,216
$159.48 P/Share
|
|
Aug 07
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.24%
|
$366,000
$183.04 P/Share
|
|
Aug 07
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.91%
|
$108,000
$54.71 P/Share
|
|
Aug 07
2019
|
R Sanders Williams Director |
SELL
Open market or private sale
|
Direct |
425
-6.79%
|
$77,775
$183.04 P/Share
|
|
Aug 04
2019
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,785
-13.74%
|
$1,268,795
$187.22 P/Share
|
|
Aug 02
2019
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
93
+3.11%
|
-
|
|
Aug 02
2019
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
160
+3.08%
|
-
|
|
Aug 01
2019
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,043
-5.17%
|
$379,998
$186.58 P/Share
|
|
Jul 03
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.24%
|
$374,000
$187.58 P/Share
|
|
Jul 03
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.91%
|
$108,000
$54.71 P/Share
|
|
Jun 05
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-12.33%
|
$350,000
$175.68 P/Share
|
|
Jun 05
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.98%
|
$108,000
$54.71 P/Share
|